Fny Investment Advisers, LLC Crispr Therapeutics Ag Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$43.23 - $73.83 $648 - $1,107	-15 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$53.19 - $79.24 $133,240 - $198,496	-2,505 Reduced 99.4%	15 $0
Q4 2021 Jan 10, 2022	BUY	$70.09 - $111.29 $176,626 - $280,450	2,520 New	2,520 $190,000
Q2 2021 Jul 14, 2021	SELL	$100.84 - $161.89 $2,016 - $3,237	-20 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$110.72 - $210.04 $2,214 - $4,200	20 New	20 $2,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.